Regulation & Policy Market Research Reports & Industry Analysis
In the United States drugs, diagnostics and medical devices are regulated by the Food and Drug Administration (FDA). The FDA is an agency of the United States Department of Health and Human Services, one of the United States federal executive departments. The FDA is responsible for protecting and promoting public health through the regulation and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED), veterinary products, and cosmetics.
The FDA derives its power from the Food, Drug and Cosmetic Act,[7] (Passed in 1938 and amended since) and are codified in Title 21, Chapter 9 of the United States Code. Some other laws that impact the FDA’s authority is Public Health Service Act, parts of the Controlled Substances Act, the Federal Anti-Tampering Act.
Regulation & Policy Industry Research & Market Reports
-
The 2023-2028 World Outlook for Orphan Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Pharmacovigilance
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2023-2028 World Outlook for Pharmacovigilance Technologies
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Pharmacovigilance and Drug Safety Software
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2023-2028 World Outlook for Counterfeit Drug Detection Devices
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
Pharmacovigilance Market, By Type of Clinical Trial Phases (Pre-clinical Studies, Clinical Trial Phase I, Clinical Trial Phase II, Clinical Trial Phase III, Post Marketing Surveillance or Phase IV), By Type of Method (Spontaneous Reporting, Intensified AD
... ADR Reporting, Targeted Reporting, Cohort Event Monitoring, EHR Monitoring), By Type of Service Providers (In-House, Contract Outsourcing), By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and ... Read More
-
The Market for Rx-to-OTC Switches, 8th Edition
... market. This has mainly been due to factors such as patent expirations, increasing competitiveness with the pharmaceutical environment, the FDA willingness to work with industry, brand re-invention, consumer demand, and cost containment strategies. The U.S. ... Read More
-
Pharmaceutical Analytical Testing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... 11,387.35 million by 2027, registering a CAGR of 8.20% from 2022 to 2027. While the sudden outbreak of the COVID-19 pandemic has negatively impacted most business sectors, the pharmaceutical analytical testing market has shown consistent ... Read More
-
IDC Perspective: Real-World Evidence and Drug Pricing in 2022
... patients, private and government healthcare payers, life science companies, and society at large. "As life science companies, private and public healthcare payers, and healthcare providers learn to use RWE to discover the true value of ... Read More
-
Testing, Inspection, and Certification Market with Covid-19 Impact Analysis by Service Type (Testing, Inspection, and Certification), Sourcing Type (In-house, Outsourced), Application and Geography - Global Forecast to 2027
... projected to reach USD 268.9 billion by 2027 from USD 221.4 billion in 2022; it is expected to grow at a CAGR of 4.0% from 2022 to 2027. The growth of the Testing, inspection, and ... Read More
-
Turkey - Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape
... Reimbursement and Competitive Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Turkey. It identifies the key trends in the country’s healthcare market and provides ... Read More
-
Orphan Drugs Market by Disease Type (Oncological Diseases, Metabolic Diseases, Hematologic & Immunologic Diseases, Infectious Diseases, Neurologic Diseases, and Other Rare Diseases): Global Opportunity Analysis and Industry Forecast, 2021–2030
... valued at $1,40,000.0 million in 2020 and is projected to reach $4,35,686.3 million by 2030 registering a CAGR of 11.8% from 2021 to 2030. The pharmaceutical agents administered to treat, diagnose, and prevent life-threatening diseases ... Read More
-
Saudi Arabia - Healthcare (Pharmaceuticals and Medical Devices), Regulatory and Reimbursement Landscape
... The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Saudi Arabia. It identifies the key trends in the country’s healthcare market and provides insights into its ... Read More
-
Global Orphan Drugs Market Research Report 2022
... in 2021, at a CAGR of 9.86% during 2022-2028. Fully considering the economic change by this health crisis, Oncology accounting for 63.30% of the Orphan Drugs global market in 2021, is projected to value US$ ... Read More
-
Global and United States Computational Toxicology Solutions Market Size, Status and Forecast 2022-2028
... Toxicology Solutions market, also covers the segmentation data of other regions in regional level and county level. Based on our recent survey, we have several different scenarios about the Computational Toxicology Solutions YoY growth rate ... Read More
-
Counterfeit Drug Detection Devices Market - Global Industry Analysis (2018 - 2020) - Growth Trends and Market Forecast (2021 - 2026)
... devices market continues to benefit significantly from the rising awareness about sizeably large markets operating on adulterated pharmaceuticals packaging, and counterfeit medicines. A new Fairfield Market Research report suggests that an increasing number of anti-counterfeiting ... Read More
-
Blockchain Market in Healthcare - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... by 2026, with a CAGR of 8.7% during the forecast period, 2021 - 2026. In 2018, the Illinois Blockchain Initiative (IBI) launched several pilots, including a birth registration pilot to develop secure identity solutions and ... Read More
-
Pharmacovigilance and Drug Safety Software Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... is expected to reach approximately USD 238.68 million in 2026, registering a CAGR of nearly 6.49% during the forecast period. The evolving threat of COVID-19 infection is adversely affecting communities, industries, businesses, and lives around ... Read More
-
Orphan Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... growth of this market include market exclusivity for orphan drug developers, the rising prevalence of rare diseases, and favorable government policies. Key Highlights The prevalence of rare diseases among the global population has been increasing ... Read More
-
Pharmacovigilance Market Size, Share & Trends Analysis Report By Product Life Cycle, By Service Provider, By Type, By Process Flow, By Therapeutic Area, By End-use, By Region, And Segment Forecasts, 2022 - 2030
... a CAGR of 10.5% from 2022 to 2030. Increasing incidence of Adverse Drug Reactions (ADRs) is the key growth driver. ADR imposes a substantial burden on healthcare systems and is one of the prominent causes ... Read More
-
Pharmaceutical Sterility Testing Market - By Type (In-House And Outsourcing), By Test Type (Sterility Testing, Bioburden Testing, And Bacterial Endotoxin Testing), By Sample (Sterile Drugs, Medical Devices, And Biologics & Therapeutics), By End-Use (Compounding Pharmacies, Medical Devices Companies, And Pharmaceutical Companies), And By Region- Global Industry Perspective, Comprehensive Analysis, And Forecast, 2021 – 2030
... Medical Devices Companies, And Pharmaceutical Companies), And By Region- Global Industry Perspective, Comprehensive Analysis, And Forecast, 2021 – 2030 Market Overview Fatpos Global has released a report titled Pharmaceutical Sterility Testing Market - Analysis of ... Read More
-
NASH Drug Pipeline and Market Overview
... of the liver (cirrhosis). No medications have been approved specifically for NASH but there are numerous products in development. NASH Drug Pipeline and Market Overview looks at the almost 80 drug candidates for the treatment ... Read More
-
Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2025
... major competitors. This report provides long-term company sales forecasts based recent market conditions. For each company covered, the report includes late stage product pipeline; late stage product pipeline by therapeutic area, comparing 2009, 2011, 2013 ... Read More
Research Assistance
